← Back to Clinical Trials
Recruiting NCT06454656

NCT06454656 A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06454656
Status Recruiting
Phase
Sponsor Royal College of Surgeons, Ireland
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 14 participants
Start Date 2024-08-12
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
MOBILE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 14 participants in total. It began in 2024-08-12 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if a new therapy approach to improve walking ability in children with Cerebral Palsy is acceptable to the children and the families in a community setting. The main questions we look to answer are: 1. Do the children/teens tolerate the therapy and feel that it is helpful? 2. Do the parents/ families feel the therapy helps and is easy to commit to? 3. Do the children/teens complete all their therapy sessions and assessments as planned? The participants will trial the therapy for 30 hours over 6 weeks and will perform assessments before and after to see if they meet their goals. They will also be interviewed to see how they felt about the therapy when they finish.

Eligibility Criteria

Inclusion Criteria: * Primary diagnosis of Cerebral Palsy (GMFCS Levels I-III) * Has a specific walking related goal * Has capacity to follow instruction * Has a primary caregiver who can support a home program Exclusion Criteria: * Has had surgery within 6 months of intervention start date * Has had botox/ baclofen within 3 months of intervention start date * Has a dual diagnosis that impacts ability to follow instruction * Has a significant cognitive impairment

Contact & Investigator

Central Contact

Caitriona M O'Shaughnessy

✉ caitrionaoshaug22@rcsi.com

📞 0833128927

Principal Investigator

Ailish Malone, PHD

PRINCIPAL INVESTIGATOR

Royal College of Surgeons

Frequently Asked Questions

Who can join the NCT06454656 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06454656 currently recruiting?

Yes, NCT06454656 is actively recruiting participants. Contact the research team at caitrionaoshaug22@rcsi.com for enrollment information.

Where is the NCT06454656 trial being conducted?

This trial is being conducted at Balrath, Ireland.

Who is sponsoring the NCT06454656 clinical trial?

NCT06454656 is sponsored by Royal College of Surgeons, Ireland. The principal investigator is Ailish Malone, PHD at Royal College of Surgeons. The trial plans to enroll 14 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology